CClinicalTrials.gg
CompletedNCT02161393LIVELYUpdated Aug 25, 2017

Physical Activity Versus Pulmonary Rehabilitation in COPD

An interventional study of Physical Activity Intervention and Pulmonary Rehabilitation Programme in Chronic Obstructive Pulmonary Disease (COPD), sponsored by University of Ulster. Completed at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-08-25.

Sponsored by University of Ulster · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary aim of this study is to assess the feasibility of conducting a trial to investigate the effectiveness of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) versus pulmonary rehabilitation in improving physical activity in COPD.

Objectives are:

(i) to assess the feasibility (patient recruitment, adherence, drop-outs and adverse events) of delivering a physical activity intervention in the COPD patient population versus pulmonary rehabilitation; (ii) to explore users perceptions relating to satisfaction and benefits of a physical activity intervention versus pulmonary rehabilitation; (iii) to investigate between and within group change in physical activity, exercise capacity, quality of life, self-efficacy and changes in the transtheoretical model with the physical activity intervention versus pulmonary rehabilitation; and (iv) to examine the cost of delivering a physical activity intervention versus pulmonary rehabilitation for patients with COPD.

The hypothesis for this study is that it will be feasible to conduct a trial that will investigate the effectiveness of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) compared to pulmonary rehabilitation for improving physical activity in COPD. The study will provide important information about interventions designed to promote and maintain physical activity, improve patient outcomes and increase patients' choice relating to exercise and physical activity interventions. It will provide a rationale and data for an adequately powered clinical trial evaluating the effects of a physical activity intervention.

Read the detailed description

A survey of pulmonary rehabilitation programmes mirrored the results of other UK studies and highlighted that there are not enough programmes available; currently in the UK less than 1.5% of patients with COPD receive pulmonary rehabilitation per year. Only a proportion of patients are targeted i.e. those with moderate to severe disease. The majority of programmes are outpatient-based and are supervised by clinicians. This structured and supervised format of pulmonary rehabilitation does not meet the needs of all patients with high numbers of dropouts and non-adherence; yet alternative options for increasing physical activity for patients with COPD currently do not seem to be offered.

A home-based pedometer-driven walking intervention offers an alternative method of delivering physical activity training that could be provided to larger numbers of patients, at a lower cost and with flexibility around life commitments. It would also provide patients with more choice when deciding whether to participate in exercise or physical activity.

To date no study has compared a home-based walking intervention to structured, supervised pulmonary rehabilitation or the patient preferences or cost of the two programmes. For this reason, there is a need to compare a home-based-walking intervention to the standard method of providing patients with physical activity training, i.e. pulmonary rehabilitation. Therefore this study is essential as it will assess the feasibility of conducting a trial to investigate the efficacy of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) versus pulmonary rehabilitation in improving physical activity in COPD.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease (COPD)

Keywords

  • Physical Activity
  • Pulmonary Rehabilitation
  • Chronic obstructive pulmonary disease
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 50 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

University of Ulster is the lead sponsor of 94 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. The Patient must be referred to pulmonary rehabilitation.
  2. The Patient must have a Primary diagnosis of COPD
  3. The Patient must have a good understanding of written English (as reported by the individual patient)
  4. The Patient must be in a stable phase (not on antibiotics at the time of assessment with the ISWT), and deemed clinically stable by the clinical pulmonary rehabilitation team.

Exclusion criteria

Exclusion Criteria:

  1. The inability to safely take part in a walking programme or pulmonary rehabilitation (e.g. unstable angina, neurological, spinal or skeletal dysfunction affecting ability to exercise)
  2. The inability to comprehend or follow instructions (e.g. dementia).
  3. Clinically unstable (Pulmonary exacerbation or any change in symptoms and medication in the last 4 weeks)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Physical Activity Intervention

    12 week home-based walking programme consisting of weekly physical activity consultations and a pedometer-driven walking programme

    Behavioral: Physical Activity Intervention

  • Active comparator
    Pulmonary Rehabilitation Programme

    6-week supervised outpatient programme consisting of twice-weekly exercise sessions and once-weekly education sessions.

    Behavioral: Pulmonary Rehabilitation Programme

Interventions

  • BehavioralPhysical Activity Intervention

    The 12 week home-based pedometer-driven walking programme will consist of weekly physical activity consultations. Pedometers will be used to set weekly step goals and motivate patients. Patients will wear the pedometer for 7 days and will record their daily steps in a step diary. At the next appointment the step target for the subsequent week will be agreed between the physiotherapist/researcher and participant. Each week thereafter the physiotherapist/researcher and patient will discuss their progress, document their mean daily step count for the previous week, and agree to a new daily step target for the subsequent week. The walking programme will be tailored to the individual and progressed on a weekly basis.

  • BehavioralPulmonary Rehabilitation Programme

    This will be a 6-week supervised outpatient programme. The exercise component will last for one hour and be delivered twice weekly. It will consist of cardiovascular exercises and lower and upper body strengthening exercises. Education sessions will be delivered once weekly. Each patient will be provided with a home exercise programme to complete unsupervised once weekly.

06

What researchers measure

Primary outcomes

  1. Change from baseline in physical activity will be assessed using step counts recorded with an Actigraph activity monitor.

    The activity monitor is worn for 7 consecutive full days prior to the intervention, and 7 full days immediately after the intervention.

    Time frame: Baseline and at 6-weeks for PR group and 12-weeks for PA group

Secondary outcomes

  1. Change from baseline in time spent in physical activity and in sitting using the International Physical Activity Questionnaire

    Time frame: Baseline and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  2. Change from baseline in exercise Capacity using the Incremental Shuttle Walk Test

    Time frame: Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  3. Change from baseline in Quality of Life using the EuroQOL-5D

    Time frame: Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  4. Change from baseline in Quality of Life using the COPD Assessment Test

    Time frame: Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  5. Stage of change in terms of physical activity using the Stages of Change Questionnaire

    The Stages of Change Questionnaire is the temporal part of the transtheoretical model. It will be used to determine the current stage of change the participant is at in terms of their physical activity behaviour.

    Time frame: Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  6. Confidence to undertake physical activity using Marcus's Self-Efficacy Questionnaire

    Marcus's Self-Efficacy Questionnaire is a component of the transtheoretical model which will provide more detailed information on each individual's confidence to undertake physical activity in different situations.

    Time frame: Baseline and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  7. Patients' perceptions of both interventions will be obtained via semi-structured interviews.

    Information will be collected with regards patient satisfaction with their exercise/activity, information regarding ease of execution, safety and tolerability of the programmes and the outcome measures, views about continuing exercise and suggestions for improving the programmes.

    Time frame: At 6-weeks for PR group and 12-weeks for PA group

  8. Feasibility of the interventions

    For both interventions information will be collected on recruitment and retention, dropouts, adherence and adverse events which will be necessary to establish feasibility.

    Time frame: End of study

  9. Global Rating of Change Questionnaire

    This is a numerical rating scale about their patient's perception of any change in their physical activity

    Time frame: At 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation

  10. Physical activity will be assessed using step counts recorded with an Actigraph activity monitor.

    Time frame: At 18 (PR group) and 24 (PA group) weeks post randomisation

07

Study locations

2 sites
  • Belfast Health and Social Care Trust
    Belfast, Co Antrim BT9 7AB, United Kingdom
  • Western Health and Social Care Trust
    Enniskillen, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02161393
Lead sponsor
University of Ulster
Collaborators
Belfast Health and Social Care Trust, Western Health and Social Care Trust, Queen's University, Belfast, KU Leuven
Responsible party
Brenda O'Neill (Senior Lecturer in Physiotherapy, University of Ulster) — Principal investigator
First posted
Jun 11, 2014
Start date
Feb 2014
Primary completion
Jan 2016
Completion
Jan 19, 2016
Last update
Aug 25, 2017

Study contacts

Brenda O'Neill, PhD
principal investigator · University of Ulster

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion